Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments

P Maiti, J Manna, GL Dunbar - Translational neurodegeneration, 2017 - Springer
Gradual degeneration and loss of dopaminergic neurons in the substantia nigra, pars
compacta and subsequent reduction of dopamine levels in striatum are associated with …

Biomarkers of Parkinson's disease: present and future

DB Miller, JP O'Callaghan - Metabolism, 2015 - Elsevier
Sporadic or idiopathic Parkinson's disease (PD) is an age-related neurodegenerative
disorder of unknown origin that ranks only second behind Alzheimer's disease (AD) in …

[HTML][HTML] Viral parkinsonism

H Jang, DA Boltz, RG Webster, RJ Smeyne - Biochimica et Biophysica Acta …, 2009 - Elsevier
Parkinson's disease is a debilitating neurological disorder characterized that affects 1–2% of
the adult population over 55 years of age. For the vast majority of cases, the etiology of this …

Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool

MPG Broen, MM Braaksma, J Patijn… - Movement …, 2012 - Wiley Online Library
Pain has been studied more intensely as a symptom of Parkinson's disease (PD) in recent
years. However, studies on the characteristics and prevalence of pain in PD have yielded …

Sigma receptors [σ Rs]: biology in normal and diseased states

CG Rousseaux, SF Greene - Journal of Receptors and Signal …, 2016 - Taylor & Francis
This review compares the biological and physiological function of Sigma receptors [σRs] and
their potential therapeutic roles. Sigma receptors are widespread in the central nervous …

Extrastriatal dopaminergic circuits of the basal ganglia

KS Rommelfanger, T Wichmann - Frontiers in neuroanatomy, 2010 - frontiersin.org
The basal ganglia are comprised of the striatum, the external and internal segment of the
globus pallidus (GPe and GPi, respectively), the subthalamic nucleus (STN), and the …

Antimuscarinic anticholinergic medications in Parkinson disease: to prescribe or deprescribe?

MJ Barrett, L Sargent, H Nawaz… - Movement Disorders …, 2021 - Wiley Online Library
The relative importance of antimuscarinic anticholinergic medications for Parkinson's
disease (PD) declined after the introduction of levodopa, such that anticholinergic …

Nonmotor symptoms in patients with Parkinson disease: A cross-sectional observational study

T Zhang, S Yu, P Guo, Y Du, Y Hu, Y Piao, L Zuo… - Medicine, 2016 - journals.lww.com
Parkinson disease (PD) is usually accompanied by numerous nonmotor symptoms (NMS),
such as neuropsychiatric symptoms, sleep disorders, autonomic dysfunctions, and sensory …

Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease

Y Sharabi, DS Goldstein - Journal of the neurological sciences, 2011 - Elsevier
Non-motor aspects of Parkinson disease (PD) are now recognized to be important both
clinically and scientifically. Among these facets are abnormalities in blood pressure …

Management of sexual dysfunction in Parkinson's disease

G Bronner, DB Vodušek - Therapeutic advances in …, 2011 - journals.sagepub.com
Nonmotor symptoms, among them sexual dysfunction, are common and underrecognized in
patients with Parkinson disease; they play a major role in the deterioration of quality of life of …